Antimitochondrial Antibody and AMA M2

Also Known As

Mitochondrial Antibody

Formal Name

Antimitochondrial Antibody and Antimitochondrial M2 Antibody

This article was last reviewed on

March 17, 2017.

This article waslast modified on November 13, 2019.

At a Glance

Why Get Tested?

To help diagnose primary biliary cholangitis, also sometimes called primary biliary cirrhosis (PBC)

When To Get Tested?

When you have abnormal results on a liver panel and/or symptoms that your healthcare practitioner suspects may be due to PBC

Sample Required?

A blood sample drawn from a vein in your arm

Test Preparation Needed?

None

You may be able to find your test results on your laboratory's website or patient portal. However, you are currently at Lab Tests Online. You may have been directed here by your lab's website in order to provide you with background information about the test(s) you had performed. You will need to return to your lab's website or portal, or contact your healthcare practitioner in order to obtain your test results.

Lab Tests Online is an award-winning patient education website offering information on laboratory tests. The content on the site, which has been reviewed by laboratory scientists and other medical professionals, provides general explanations of what results might mean for each test listed on the site, such as what a high or low value might suggest to your healthcare practitioner about your health or medical condition.

The reference ranges for your tests can be found on your laboratory report. They are typically found to the right of your results.

If you do not have your lab report, consult your healthcare provider or the laboratory that performed the test(s) to obtain the reference range.

Laboratory test results are not meaningful by themselves. Their meaning comes from comparison to reference ranges. Reference ranges are the values expected for a healthy person. They are sometimes called "normal" values. By comparing your test results with reference values, you and your healthcare provider can see if any of your test results fall outside the range of expected values. Values that are outside expected ranges can provide clues to help identify possible conditions or diseases.

While accuracy of laboratory testing has significantly evolved over the past few decades, some lab-to-lab variability can occur due to differences in testing equipment, chemical reagents, and techniques. This is a reason why so few reference ranges are provided on this site. It is important to know that you must use the range supplied by the laboratory that performed your test to evaluate whether your results are "within normal limits."

For more information, please read the article Reference Ranges and What They Mean.

What is being tested?

Antimitochondrial antibodies (AMA) are autoantibodies that are strongly associated with primary biliary cholangitis (PBC), formerly called primary biliary cirrhosis. This test detects and measures the amount (titer) of AMA in the blood.

Primary biliary cholangitis is a chronic autoimmune disorder that causes inflammation and scarring of the bile ducts inside the liver. It is a slow-progressing disease that causes worsening liver destruction and blockage of the bile flow. Blocked bile ducts can lead to a build-up of harmful substances within the liver and may eventually lead to permanent scarring (cirrhosis). PBC is found most frequently in women between the ages of 35 and 60. About 90-95% of those affected by PBC will have significant titers of antimitochondrial antibodies.

AMA are autoantibodies that develop against antigens within the body. There are nine types of AMA antigens (M1 – M9) of which M2 and M9 are the most likely to cause illness (clinically significant). The presence of the M2 type of AMA has been particularly evident in PBC, while the other types may be found in other conditions. Some laboratories offer the AMA-M2 as a more specific test for PBC.

For more information on PBC, see the links in the Related Pages section.

How is the sample collected for testing?

A blood sample is obtained by inserting a needle into a vein in the arm.

Is any test preparation needed to ensure the quality of the sample?

No test preparation is needed.

Common Questions

How is it used?
The antimitochondrial antibody (AMA) test or the AMA-M2 test may be ordered to help diagnose primary biliary cholangitis (PBC).

Other tests that may be ordered include:

Smooth muscle antibodies (SMA)

Antinuclear antibodies (ANA)

Alkaline phosphatase (ALP)

IgM level

Bilirubin

Albumin

Prothrombin time (PT)

C-reactive protein (CRP)

GGT

These tests often help detect PBC, distinguishing it from other autoimmune conditions causing liver damage, and may be useful in helping to predict whether a person may need a liver transplant.
When is it ordered?
The AMA or AMA-M2 test is ordered when a healthcare practitioner suspects that someone has an autoimmune disorder such as PBC that is affecting the liver. A person may have symptoms that include:

Itching (pruritus)

Jaundice

Fatigue

Abdominal pain

Enlarged liver

Many of those affected with early PBC do not have any symptoms. The condition is often initially identified because a person has abnormal results on a liver panel (elevated liver enzymes), especially alkaline phosphatase (ALP).

An AMA or AMA-M2 test may be ordered along with or following a variety of tests that are used to help diagnose and/or rule out other causes of liver disease or injury. These causes can include infections, such as viral hepatitis, drugs, alcohol abuse, toxins, genetic conditions, metabolic conditions, and autoimmune hepatitis.
What does the test result mean?

A high AMA or AMA-M2 level (titer) in the blood indicates that the most likely cause of symptoms and/or liver damage is PBC. The level of AMA is not related to the severity of PBC symptoms or to a person's prognosis.

A negative AMA or AMA-M2 means that it is likely that a person's symptoms are due to something other than PBC, but the result does not rule out the condition. About 5-10% of those with PBC will not have significant amounts of AMA or AMA-M2.
Is there anything else I should know?

By themselves, AMA and AMA-M2 are not diagnostic of PBC, but in conjunction with other laboratory tests and clinical symptoms, the diagnosis of PBC can be made. A liver biopsy may be performed to look for characteristic signs of PBC in the liver tissue and to confirm the diagnosis but is not always necessary. Imaging scans of the liver may also be ordered to look for bile duct obstructions.

About 50% of the cases of PBC will be discovered before a person has noticeable symptoms.
What causes primary biliary cholangitis (PBC)?

The cause is currently not known. It is not infectious and not inherited, although an increased susceptibility to develop autoimmune disorders may occur in some families. It can occur in anyone at any age, but it is primarily seen in middle-aged women.
How fast does PBC progress?

The course and severity of PBC is difficult to predict. Many people will have no or few symptoms for many years. For more information, consult with your healthcare practitioner and see the links in the Related Pages section.
Can I have an AMA or AMA-M2 test done in my healthcare practitioner's office?

No, the test requires specialized equipment and will not be offered by all laboratories. Your blood will likely be sent to a reference laboratory.
If I have AMA, will the antibodies ever go away?

The level of antibody (titer) may vary over time but, in most cases, once a person has detectable AMA, that person will continue to do so.

See More Common Questions See Less Common Questions

On This Site

Tests: ANCA/MPO/PR3 Antibodies, Liver/Kidney Microsomal Antibody, ALP, ALT, Liver Panel, Smooth Muscle Antibody, ANA

Conditions: Autoimmune Diseases, Liver Disease, Hepatitis, Cirrhosis

Elsewhere On The Web

American Liver Foundation: Primary Biliary Cholangitis (PBC, previously Primary Biliary Cirrhosis)
MedlinePlus Medical Encyclopedia: Primary biliary cirrhosis
NIDDK: Primary Biliary Cirrhosis
Mayo Clinic: Primary biliary cirrhosis

View Sources

Sources Used in Current Review

Pyrsopoulos, N. and Reddy, K. (2016 June 3 Updated). Primary Biliary Cholangitis (Primary Biliary Cirrhosis). Medscape Drugs and Diseases. Available online at http://emedicine.medscape.com/article/171117-overview. Accessed on 02/18/17.

Lal, S. (2016 May 11 Updated). Primary biliary cirrhosis. MedlinePlus Medical Encyclopedia. Available online at https://medlineplus.gov/ency/article/000282.htm. Accessed on 02/18/17.

(2016 December 6, Updated). Primary Biliary Cholangitis (PBC, previously Primary Biliary Cirrhosis). American Liver Foundation. Available online at http://www.liverfoundation.org/abouttheliver/info/pbc/. Accessed on 02/18/17.

Tebo, A. (2016 November Updated). Primary Biliary Cirrhosis – PBC. ARUP Consult. Available online at https://arupconsult.com/content/primary-biliary-cirrhosis. Accessed on 02/18/17.

Shin, Y. (2014 December 5, Updated). Antimitochondrial Antibody. Medscape Laboratory Medicine. Available online at http://emedicine.medscape.com/article/2086548-overview Accessed on 02/18/17.

(2014 April Updated). Primary Biliary Cirrhosis. National Institute of Diabetes and Digestive and Kidney Diseases Available online at https://www.niddk.nih.gov/health-information/liver-disease/primary-biliary-cirrhosis. Accessed on 02/18/17.

(© 1995–2017). Mitochondrial Antibodies (M2), Serum. Mayo Clinic Mayo Medical Laboratories. Available online at http://www.mayomedicallaboratories.com/test-catalog/Clinical+and+Interpretive/8176. Accessed on 02/18/17.

Sources Used in Previous Reviews

Thomas, Clayton L., Editor (1997). Taber's Cyclopedic Medical Dictionary. F.A. Davis Company, Philadelphia, PA [18th Edition].

Pagana, Kathleen D. & Pagana, Timothy J. (2001). Mosby's Diagnostic and Laboratory Test Reference 5th Edition: Mosby, Inc., Saint Louis, MO. Pp 82-83.

(© 1995-2005). Primary Biliary Cirrhosis. The Merck Manual of Medical Information – Second Home Edition [On-line information]. Available online at http://www.merck.com/mmhe/print/sec10/ch136/ch136d.html.

(© 1995-2005). Primary Sclerosing Cholangitis. The Merck Manual of Medical Information – Second Home Edition [On-line information]. Available online at http://www.merck.com/mmhe/sec10/ch136/ch136e.html.

Beuers, U. and Rust, C. (2005 October 27). Overlap Syndromes. Medscape, from Semin Liver Dis. 2005; 25(3): 311-320. [On-line information]. Available online at http://www.medscape.com/viewarticle/512463.

Stone, C. (2004 November 10, Updated). Autoimmune liver disease panel. MedlinePlus Medical Encyclopedia [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/003328.htm.

Stone, C. (2004 May 14). Primary biliary cirrhosis. MedlinePlus Medical Encyclopedia [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/000282.htm.

Peng, S. (2005 April 20). Antimitochondrial antibody. MedlinePlus Medical Encyclopedia [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/003529.htm.

Dugdale, D. (Updated 2008 November 2). Autoimmune liver disease panel. MedlinePlus Medical Encyclopedia [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/003328.htm. Accessed 1/29/09.

Christopher-Stine, L. (Updated 2006 August 22). Systemic lupus erythematosus. MedlinePlus Medical Encyclopedia [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/000435.htm. Accessed 1/29/09.

Lehrer, J (2006 July 25 Updated). Autoimmune hepatitis. MedlinePlus Medical Encyclopedia [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/000245.htm. Accessed 1/29/09.

Stone, C. (2008 May 20, Updated). Primary biliary cirrhosis. MedlinePlus Medical Encyclopedia [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/000282.htm. Accessed 1/29/09.

Hill, H. (Updated 2008 September). Primary Biliary Cirrhosis. ARUP Consult [On-line information]. Available online at http://www.arupconsult.com/Topics/AutoimmuneDz/PBC.html#. Accessed 1/29/09.

Bylund DJ, Nakamura RM. Organ-specific autoimmune diseases. Henry’s Clinical Diagnosis and Laboratory Management, 21st ed., 2007. Pp 945-960.

(Updated 2012 September 26). Antimitochondrial Antibody. Medscape Reference [On-line information]. Available online at http://emedicine.medscape.com/article/2086548-overview#showall. Accessed February 2013.

Tebo, A. (Updated 2012 August). Primary Biliary Cirrhosis – PBC. ARUP Consult [On-line information]. Available online at http://www.arupconsult.com/Topics/PBC.html?client_ID=LTD#tabs=0. Accessed February 2013.

(© 1995–2013). Mitochondrial Antibodies (M2), Serum. Mayo Clinic Mayo Medical Laboratories [On-line information]. Available online at http://www.mayomedicallaboratories.com/test-catalog/Overview/8176. Accessed February 2013.

Makover, M. (Updeate 2011 February 10). Antimitochondrial antibody. MedlinePlus Medical Encyclopedia [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/003529.htm. Accessed February 2013.

Pyrsopoulos, N. and Reddy, K. (Updated 2012 January 4). Primary Biliary Cirrhosis. Medscape Reference [On-line information]. Available online at http://emedicine.medscape.com/article/171117-overview. Accessed February 2013.

Dugdale, D. (Updated 2012 May 1). Primary biliary cirrhosis. MedlinePlus Medical Encyclopedia [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/000282.htm. Accessed February 2013.

Shaffer, E. (Reviewed 2009 June) Laboratory Tests of the Liver and Gallbladder. Merck Manual for Healthcare Professionals [On-line information]. Available online through http://www.merckmanuals.com. Accessed February 2013.

Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL eds, (2005). Harrison's Principles of Internal Medicine, 16th Edition, McGraw Hill, Pp 1860-1861.

(April 30, 2012) National Digestive Diseases Information Clearinghouse. Primary Biliary Cirrhosis. Available online at http://digestive.niddk.nih.gov/ddiseases/pubs/primarybiliarycirrhosis/index.aspx. Accessed May 2013.

Ask a Laboratory Scientist

This form enables patients to ask specific questions about lab tests. Your questions will be answered by a laboratory scientist as part of a voluntary service provided by one of our partners, American Society for Clinical Laboratory Science. Please allow 2-3 business days for an email response from one of the volunteers on the Consumer Information Response Team.

Please indicate whether you are a

Country

I have read and agree to the Privacy Policy (read the Privacy Policy)

I have read and agree to the Terms of Use (read the Terms of Use)

I agree to the disclaimer (read the disclaimer).

Disclaimer

Thank you for using the Consumer Information Response Service ("the Service") to inquire about the meaning of your lab test results. The Service is provided free of charge by the American Society for Clinical Laboratory Science, which is one of many laboratory organizations that supports Lab Tests Online.
Please note that information provided through this free Service is not intended to be medical advice and should not be relied on as such. Although the laboratory provides the largest single source of objective, scientific data on patient status, it is only one part of a complex biological picture of health or disease. As professional clinical laboratory scientists, our goal is to assist you in understanding the purpose of laboratory tests and the general meaning of your laboratory results. It is important that you communicate with your physician so that together you can integrate the pertinent information, such as age, ethnicity, health history, signs and symptoms, laboratory and other procedures (radiology, endoscopy, etc.), to determine your health status. The information provided through this Service is not intended to substitute for such consultations with your physician nor specific medical advice to your health condition.
By submitting your question to this Service, you agree to waive, release, and hold harmless the American Society for Clinical Laboratory Science and its affiliates or their past or present officers, directors, employees, agents, and Service volunteers (collectively referred to as "ASCLS") and the American Association for Clinical Chemistry and its affiliates or their past or present officers, directors, employees, agents, and Service volunteers (collectively referred to as "AACC") from any legal claims, rights, or causes of action you may have in connection with the responses provided to the questions that you submit to the Service.
AACC, ASCLS and its Service volunteers disclaim any liability arising out of your use of this Service or for any adverse outcome from your use of the information provided by this Service for any reason, including but not limited to any misunderstanding or misinterpretation of the information provided through this Service.

See More See Less